ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 1582 • ACR Convergence 2020

    Average Follow-up Time After Telemedicine Visit Is Longer Than Conventional Face-to-Face Visit in Outpatient Rheumatology Practice During COVID-19 Pandemic

    Deepan Dalal1, Tzu-Chun Chu2, Brad Crough3, Janine Molino2, David Hemendinger4 and Bharat Ramratnam2, 1Brown University, East Providence, RI, 2Brown University, Providence, RI, 3Brown Physicians Incorporation, East Providence, RI, 4Brown Physicians Incorporation, Providence, RI

    Background/Purpose: In the era of recent COVID-19 crisis, outpatient rheumatology practices resorted to telemedicine to deliver longitudinal care, a fundamental component of chronic disease management. …
  • Abstract Number: 0577 • ACR Convergence 2020

    Qualitative Review of Unsuccessful Pilot Study of Super-Utilizer Systemic Lupus Erythematosus (SLE) Patients Enrollment into Team Based Program to Improve Patient Outcomes

    Sarah Min1, Devy Setyono2, Sunghye Kim3, Feben Girma1, Melanie Martin1 and Rachel Wolfe1, 1Wake Forest Baptist Medical Center, Winston-Salem, NC, 2Emkey Arthritis and Osteoporosis Clinic, Wyomissing, PA, 3W.G. Hefner VA Medical Center, Salisbury, NC

    Background/Purpose: SLE is a chronic multi-system autoimmune disease, affecting mostly women of child-bearing age and more racial minorities, with a wide spectrum of outcomes: from…
  • Abstract Number: 0605 • ACR Convergence 2020

    How Did SARS-CoV2/COVID-19 Pandemic Affected Rheumatology Practice in Latin America? A Regional Survey from PANLAR

    Daniel Fernández-Ávila1, Julián Barahona-Correa1, Diana Romero-Alvernia1, Sergio Kowalski2, Ana María Sapag Durán3, Antonio Cachafeiro Vilar4, Belia Lucía Meléndez Muñoz5, Carlos Santiago Pastelín6, Daniel Palleiro Rivero7, Dina María Arrieta8, Guillermo Pons-Estel9, Jossiell Then Báez10, Manuel Ugarte-Gil11, Mario Cardiel12, Nelly Colman13, Nilmo Chávez Pérez14, Paula Burgos15, Rubén Montufar16, Sayonara Sandino17, Yurilis Fuentes-Silva18 and Enrique Soriano19, 1Pontificia Universidad Javeriana - Hospital Universitario San Ignacio, Bogota, Colombia, 2Unidad de Investigación PANLAR. Universidade Federal do Paraná, Paraná, Brazil, 3Hospital Universitario Japonés, Santa Cruz, Bolivia, 4Pacífica Salud - Hospital Punta Pacífica,, Ciudad de Panamá, Panama, 5Hospital de la Policía Nacional N1 Quito, Quito, Ecuador, 6Instituto Hondureño de la Seguridad Social, Tegucigalpa, Honduras, 7Instituto Nacional de Reumatología del Uruguay - Universidad de la República, Montevideo, Uruguay, 8Hospital México, San José de Costa Rica, Costa Rica, 9Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, 10Hospital Metropolitano de Santiago (HOMS), Santiago, Dominican Republic, 11Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen and Universidad Científica del Sur, Lima, Peru, 12Centro de Investigación Clínica de Morelia, Morelia, Mexico, 13Hospital de Clínicas - Universidad Nacional de Asunción, Asunción, Paraguay, 14Instituto Guatemalteco de Seguridad Social, Ciudad de Guatemala, Guatemala, 15Universidad Católica de Chile, Santiago de Chile, Chile, 16Consultorio de Especialidades del Instituto Salvadoreño del Seguro Social, San Salvador, El Salvador, 17Policlínica Nicaragüense, Managua, Nicaragua, 18Centro Clínico Universitario de Oriente - Universidad de Oriente, Ciudad Bolivar, Venezuela, 19Department of Public Health, Instituto Universitario, Escuela de Medicina Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Capital Federal, Buenos Aires, Argentina

    Background/Purpose: Since December 2019, a novel coronavirus (SARS-CoV-2) pandemic was declared. Social isolation became a mainstay for the prevention of disease expansion. Outpatient follow-up of…
  • Abstract Number: 1594 • ACR Convergence 2020

    Hydroxychloroquine Prescribing Habits and Provider Opinion on Dosing Guidelines in the Rheumatology and Dermatology Practices of an Academic Institution

    Rebecca Overbury1, Jakrapun Pupaibool2, Christopher Hansen2 and Dorota Lebiedz-Odrobina2, 1University of Utah and Primary Children's Hospital, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT

    Background/Purpose: One rare but devastating adverse event related to the use of hydroxychloroquine (HCQ) is retinal toxicity. Retinal toxicity rates from HCQ can be as…
  • Abstract Number: 0578 • ACR Convergence 2020

    Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics

    Rian Penford1, Angela Reith1, Elaine Wren1 and Kirsten Mackay1, 1Torbay and South Devon NHS Foundation Trust, Torquay, United Kingdom

    Background/Purpose: Until the COVID 19 crisis we initiated DMARD(s) and Biologic therapies using shared medical clinics. More than 30 patients could seen per week, with…
  • Abstract Number: 0606 • ACR Convergence 2020

    A Systematic Review Exploring Pre-COVID-19 Telehealthcare Models Used in the Management of Patients with Rheumatological Disease

    Alexandra Nelson1 and Marina Anderson2, 1University of Liverpool, Liverpool, United Kingdom, 2Lancaster University, Lancaster, United Kingdom

    Background/Purpose: Recent advancements in the delivery and utilization of information and communication technologies (ICTs) have led to an increased application of telehealthcare services. Global coronavirus…
  • Abstract Number: 1610 • ACR Convergence 2020

    Cutaneous Side Effects of Hydroxychloroquine in Rheumatic Diseases –Combination of “Traditional” Multivariate Analysis for Risk Factors AndClassification Model Development Using Supervised Machine Learning –Single Centre Retrospective Cohort Study in India

    Sandeep Surendran1, Mithun CB1, Arun Tiwari2, Vishal Marwaha1 and Sekhar Easwar1, 1Amrita Institute of Medical Sciences, Kochi, Kerala, India., Kochi, Kerala, India, 2Amrita Institute of Medical Sciences, Kochi, Kerala, India., Kochi, India

    Background/Purpose: Hydroxychloroquine (HCQ) is associated with varied cutaneous side effects but only few studies in literature characterizing the risk factors for this. Recently machine learning…
  • Abstract Number: 0580 • ACR Convergence 2020

    Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting

    Kevin Ong1, Jack Farr2, Louis McIntyre3, Andrew Gudeman2, Iain Murray4, Charles Hummer5, Wilson Ngai6, Heather Good7, Edmund Lau8 and Roy Altman9, 1Exponent, Philadelphia, 2Indiana University Department of Orthopaedic Surgery, Indianapolis, 3US Orthopedics, Tarrytown, 4Department of Orthopaedics, The University of Edinburgh, Edinburgh, United Kingdom, 5Premier Orthopaedics and Sports Medicine, Glen Mills, 6Sanofi US, Bridgewater, 7Sanofi US, Bridgewater, FL, 8Exponent, Menlo Park, 9David Geffen School of Medicine, University of California, Agua Dulce, CA

    Background/Purpose: Case reports of severe acute localized reactions (SALR) following intra-articular (IA) hyaluronic acid (HA) injections for knee osteoarthritis (OA) have been described. These have…
  • Abstract Number: 0608 • ACR Convergence 2020

    Patient and Parent Perspectives in a Academic Pediatric Rheumatology Transition Clinic

    Rebecca Overbury1, Tracy Frech2, John Bohnsack3, CJ Inman1, Sara Stern1, Karen James1, Erin Treemarcki4 and Aimee Hersh4, 1University of Utah and Primary Children's Hospital, Salt Lake City, UT, 2University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT, 3University of Utah and Primary Children's Hospital, Cincinnati, OH, 4University of Utah and Primary Children's Hospital, Salt Lake City

    Background/Purpose: In November 2018 we initiated a transition clinic called ACCORD (Adult Center for Childhood Onset Rheumatic Disease). Our unique structure integrates an adult rheumatologist…
  • Abstract Number: 1621 • ACR Convergence 2020

    Cervical Cancer Screening Among Women with Systemic Lupus Erythematosus or Prescribed Tumor Necrosis Alpha-inhibitors Who Receive Outpatient Rheumatology Care

    Mehret Birru Talabi1, Kwonho Jeong1, Kaleab Abebe1, Megan Clowse2, Robyn Domsic3 and Sonya Borrero1, 1University of Pittsburgh, Pittsburgh, PA, 2Duke University, Chapel Hill, NC, 3University of Pittsburgh School of Medicine, Pittsburgh, PA

    Background/Purpose: Cervical cancer screening is important for women with systemic lupus erythematosus (SLE) and women prescribed TNF-alpha inhibitors (TNFi), as they have an increased risk…
  • Abstract Number: 0583 • ACR Convergence 2020

    Cost of Illness in Patients with Psoriasis and Psoriatic Arthritis

    Santos Castañeda1, Esther Francisca Vicente-Rabaneda2, Mar Llamas-Velasco3, Javier Sánchez-Pérez3, José Pardo4, Rita Cabeza-Martínez5, Mercedes Miranda-Fontes6, Juan Márquez7, Jaime Calvo-Alén8, Susana Armesto9, Isabel Belinchón10, Alejandro Gómez11, María Dolores Miranda12, Silvia Martínez-Pardo13, Leticia Merino Melendez14, Miguel Ángel Casado15, María Yébenes15 and Araceli Casado15, 1Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 2Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 3Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Madrid, Spain, 4H.G.U. Santa Lucía, Cartagena, Murcia, Spain, 5H.U. Puerta de Hierro Majadahonda, Madrid, Madrid, Spain, 6H.U. Río Hortega, Valladolid, Valladolid, Castilla y Leon, Spain, 7H.G. Jerez de la Frontera, Cádiz, Andalucia, Spain, 8Hospital Universitario Araba, Vitoria-Gasteiz, Pais Vasco, Spain, 9H.U. Marqués de Valdecilla, Santander, Cantabria, Spain, 10H.G.U. Alicante, Alicante, Comunidad Valenciana, Spain, 11H.U. Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain, 12H.G. San Agustín de Linares, Jaen, Andalucia, Spain, 13H. Mutua de Terrassa, Barcelona, Catalonia, Spain, 14H. San Pedro, Logroño, Spain, 15Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Madrid, Spain

    Background/Purpose: Psoriasis (Ps) and psoriatic arthritis (PsA) have a major impact on patients’ health-related quality of life. Cost of illness of patients with Ps, PsA and…
  • Abstract Number: 0610 • ACR Convergence 2020

    Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak

    Kent Kwas Huston1, Nehad Soloman2, Janna Radtchenko3, Simon Helfgott4, Jasvinder Singh5 and Colin Edgerton6, 1Kansas City Physician Partners, Kansas City, MO, 2Arizona Arthritis & Rheumatology Associates, P.C., Peoria, AZ, 3Trio Health, Louisville, CO, 4BWH- HMS, Boston, MA, 5University of Alabama at Birmingham, Birmingham, AL, 6Articularis Healthcare, Summerville, SC

    Background/Purpose: Patients (pts) with autoimmune diseases managed by rheumatologists represent vulnerable population with risk of serious complications if exposed to novel coronavirus SARS-CoV2. The first…
  • Abstract Number: 1684 • ACR Convergence 2020

    Increase in Emergency Department Visits and Hospitalizations, Decrease in Outpatient Visits Following Transition to Adult Rheumatologic Care

    Paul Jensen1, Jessica Greco2, Kenneth Jackson3 and Stacy Ardoin4, 1Intermountain Healthcare, St. George, UT, 2Ohio State University/Nationwide Children's Hospital, Columbus, OH, 3Ohio State University Medical Center, Columbus, OH, 4Nationwide Children's Hospital, Columbus, OH

    Background/Purpose: Many children with rheumatic disease have active disease as adults, and health care gaps often occur in the transition from pediatric to adult care.…
  • Abstract Number: 0587 • ACR Convergence 2020

    Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic

    Alfredo Aguirre1, Laura Trupin1, Sarah Patterson2, Kimberly DeQuattro2, Patricia Katz3, Cristina Lanata2, Stephanie Rush1, Lindsey Criswell4, Maria Dall'Era5 and Jinoos Yazdany1, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3University of California, San Francisco, Novato, CA, 4Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, University of California San Francisco, San Francisco, CA, 5Division of Rheumatology, University of California, San Francisco, CA

    Background/Purpose: The pandemic of coronavirus disease 19 (COVID-19) has led to widespread disruptions across the spectrum of healthcare. We sought to investigate barriers to medical…
  • Abstract Number: 0612 • ACR Convergence 2020

    Differences in 30-Day Rehospitalization Risk and Predictors by Age Group Among Patients with Lupus in Medicare

    Maria Schletzbaum1, Yi Chen2, Ann Sheehy3, Farah Kaiksow3, Ryan Powell4, Andrea Gilmore-Bykovskyi5, Amy Kind6 and Christie Bartels7, 1University of Wisconsin-Madison School of Medicine and Public Health, Department of Population Health Sciences, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Department of Biostatistics and Medical Informatics, Madison, WI, 3University of Wisconsin School of Medicine and Public Health, Department of Medicine, Hospital Medicine Division, Madison, WI, 4University of Wisconsin School of Medicine and Public Health, Department of Medicine, Geriatrics Division, Madison, WI, 5University of Wisconsin - Madison, School of Nursing, Madison, WI, 6University of Wisconsin-Madison School of Medicine and Public Health, Department of Medicine, Health Services and Care Research Program, Geriatrics Division, Madison, WI, 7University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI

    Background/Purpose: Although our recent research demonstrates that young adult Medicare beneficiaries (age 18-35) with lupus (SLE) have higher risk of 30-day rehospitalization, predictors specific to…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology